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The hydropathic profile, secondary structure, epitope and binding site of the a-melanotropin
molecule were investigated. It was shown that the standard algorithm according to Kyte and
Doolittle may be combined with complex methods of the secondary structure prediction to ex-
tract the information relevant for the epitope location and modeling. The binding ligand-recep-
tor motifs of the hormone were investigated by means of the SSpro8 method. The Molecular
Recognition Theory combined with an NCBInr protein database search was applied to find the
possible paratope (receptor) structures for the predicted a-melanotropin epitope (ligand). The
described concept constitutes a useful and simple set of procedures for deriving new biologi-
cally active peptides and antibodies and also for performing modulation of peptide-receptor in-
teraction.
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INTRODUCTION
Pro-opiomelanocortin (POMC) hormone is synthetized
in the gland.1 Several important and biologically active
peptides are derived from the large POMC precursor
molecule.1,2 Among them are melanotropins (a-, b- and
g-MSH), potent endogenous inhibitors of inflamma-
tion.1,2 Melanotropins share a common amino acid motif
HFRW and exert their effects by activating seven-trans-
membrane domain G-protein-coupled melanocortin re-
ceptors (MCR).2–4 During the last decade, five members
of this receptor family, MC1R to MC5R, have been
characterized and cloned.1–4
Proteolytic cleavage of POMC is done by pro-hor-
mone convertases PC1 and PC2.2 First, PC1 leads to the
adrenocorticotrophic hormone (ACTH) and subsequent-
ly PC2 leads to the formation of alpha-melanotropin,
i.e., a-MSH.2 Alpha-melanotropin is an ancient, evo-
lutionally conserved, tri-decapeptide that corresponds to
the first 13 amino acids of ACTH.2,5,6 It is the most
widely studied peptide in the context of inflammation,
involved in the host reaction to infectious and inflamma-
tory stimuli in humans.2,5,6 Some of its protective mecha-
nisms include a compensatory increase in the presence
of inflammation,5–7 reduction of proinflamatory cyto-
kine synthesis, and antipyretic effects.2,5–7 Anti-inflam-
matory effects of the peptide are thought to be mediated
through MCR1, MCR3, MC4 and MCR5.
In this study, we investigated and modelled hydro-
phobicity, secondary structure, receptor binding site, anti-
genicity and molecular recognition of the a-melanotro-
pin peptide and its possible receptor targets.
METHODS
Hydrophobicity Analyses
The hydrophobicity profile of a-melanotropin was ana-
lyzed by means of the algorithm by Kyte & Doolittle.8,9
The values of amino acid hydrophobicity presented in
Table I were averaged over a segment of 7 residues and
plotted (Figure 1). This procedure enables the prediction
of exposed loops, including epitopes.9
Secondary Structure Prediction
Analysis and prediction of the a-melanotropin structure
(Table II) was done by means of the SSpro8 structure
prediction method.10–11 SSpro is a server for protein sec-
ondary structure prediction based on an ensemble of 11
BRNNs (bidirectional recurrent neural networks).10–11
This secondary structure prediction procedure is an ex-
tension to SSpro and adopts the full DSSP 8-class output
classification as follows:
1. H: a-helix
2. G: 310-helix
3. I: p-helix
4. E: b-strand
5. B: b-bridge
6. T: b-turn
7. S: bend
8. C: the rest
The system is available online (based on PSI-BLAST
profiles) and may be found at the address: http://www.
igb.uci.edu/tools/scratch/.
Molecular Recognition of the Receptor
According to the Molecular Recognition Theory (MRT),
sense and antisense peptides have mutually complemen-
tary shapes, which results in their interaction.12–18 This
is due to the fact that in antisense (complementary) pep-
tides, due to the genetic code, hydrophilic and hydro-
phobic patterns of amino acid polarity are changed into
the opposite ones.12–18 Table I presents complementary
(antisense) peptide pairs arising from the genetic code
table.14–16
MRT was used to extract an antisense peptide com-
plementary to a-melanotropin and its paratope motif lo-
cated at the amino acid positions 5–8. This quadri-
peptide (LVKA) is an MRT antisense transcript of the
a-melanotropin epitope predicted by means of the Kyte
& Doolittle algorithm and SSpro8 structure prediction
method (Figure 1, Tables I-II). A ProteinInfo sequence
search of the NCBInr database was used to locate mo-
lecular receptors for the LVKA natural ligand (EHFR
motif of a-melanotropin).
Kyte & Doolitttle hydropathic amino acid scores of
the antisense peptide pairs in Table I exhibit strong neg-
ative correlation to the receptor amino acid values (r =
–0.94).16 Codons coding for hydrophilic amino acids are
mostly complemented by the antisense codons for hy-
drophobic ones (87.5 %), and vice versa (63.6 %).16
Otherwise, matching amino acids belong to the neutral
group.16 Neutral amino acids are in most cases (62.5 %)
complemented by the neutral ones, and in the few cases
of exception either by polar (12.5 %) or nonpolar amino
acids (25 %).16
RESULTS AND DISCUSSION
Sequence Analyses
The simplest analysis of a protein sequence is a hydro-
phobicity plot of the amino acid hydropathy along the
chain.8,9,19 It is used to predict the positions of exposed
and buried residues, antigenic sites, membrane-spanning
regions and turns between elements of the secondary
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TABLE I. Antisense (complementary) pairs of amino acids for pep-
tides and proteins
Amino acid
(aa)
Kyte &
Doolittle
hydropathy
Natural
antisense
(transcribed
3’→5’)
Antisense
(transcribed
5’→3’)
I (Isoleucine) 4.5 Y Y, N, D
V (Valine) 4.2 H, Q H, N, D, Y
L (Leucine) 3.7 N, E, D E, K, Q
F (Phenylalanine) 2.7 K K, E
C (Cysteine) 2.5 T T, A
M (Methionine) 1.9 Y H
A (Alanine) 1.8 R R, G, S, C
G (Glycine) –0.4 P P, S, T, A
T (Threonine) –0.7 C, W G, S, C, R
W (Tryptophan) –0.9 T P
S (Serine) –0.9 S, R R, G, T, A
Y (Tyrosine) –1.3 M, I I, V
P (Proline) –1.6 G G, W, R
H (Histidine) –3.2 V V, M
D (Aspartic acid) –3.5 L I, V
E (Glutamic acid) –3.5 L L, F
N (Asparagine) –3.5 L I, V
Q (Glutamine) –3.5 V L
K (Lysine) –3.9 F F, L
R (Arginine) –4.5 A, S A, S, P, T
structure.8,9,19 The standard Kyte & Doolittle algorithm
uses amino acid hydropathy values averaged over a
short segment, 7 residues, to predict exposed loops/epi-
topes. The transmembrane regions are analyzed by ave-
raging a segment of 15 to 19 residues.8,9 Positive values,
usually >1.6, point to the transmembrane segment, while
negative ones point to the exposed loops/antigenic site.8,9
The analysis of the a-melanotropin sequence, with
Kyte & Doolittle hydropathy values averaged over a
segment of 7 residues, is shown in Figure 1. It can be
clearly seen that hydrophilicity is prominent for the
a-melanotropin amino acids 5–9 with the peak at amino
acids 8 (R) and 9 (W). The hydrophilic amino acid motif
6–9 (HFRW) is known as the part of the melanotropin
molecule important for its receptor binding.2–4 This mo-
tif is shared by all melanotropin peptides (a-, b- and
g-MSH).2 The peptide structure was additionally investi-
gated by means of the SSpro8 method. Table II confir-
med that the first four amino acids of the a-melanotro-
pin binding site EHFRW (aa 5–9) constitute an extended
strand, i.e., b-strand, whereas the last amino acid W
along with the next one G belong to a part which was
defined as b-turn.
Molecular Recognition
The Molecular Recognition Theory is based on the ob-
servation that peptides consisting of amino acids speci-
fied by the complementary (antisense) RNA codons bind
to each other with higher specificity and efficacy than
peptides not specified by the complementary co-
dons.12–18 According to this theory, sense-antisense pep-
tide pairs behave as ligand-receptor systems.12–16
Interacting antisense pairs are often defined from
the genetic code table read in natural 3’→ 5’ direction
(Table I).16 Reverse reading in 5’→ 3’ direction may be
also applied for the antisense peptide design.16 The latter
is due to the fact that the hydropathic character of an
amino acid residue is related to the middle letter of the
messenger RNA codon triplets, which remains the same
regardless of the direction of transcription.13,16 This con-
cept has been successfully applied to more than 40 com-
plementary peptide-receptor systems.13–18
Table I shows that in contrast to the small number of
27 possible antisense amino acids read in 3’→ 5’
direction, 52 possible antisense amino acid combinations
for 20 possible amino acids of the sense peptide were
obtained in 5’→ 3’ direction. Consequently, for a peptide
of the amino acid chain length n, the average number of
all possible antisense peptide substitutions N read in
3→ 5’ direction is relatively small, i.e., N = n1.35, whereas
in 5’→ 3’ direction many more possible substitutions
exist (N = n2.6) (Table I, Figure 2). Therefore, antisense
peptide readings in 3→ 5 direction are more suitable for
rational peptide design of the interacting ligand-receptor
systems, or antigen-antibody complexes.16
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Figure 1. Hydropathy patterns of a-melanotropin and its 3’→5’
antisense peptide over a 7-residue-segment (amino acids 4–10).
TABLE II. Secondary structures of a-melanotropin and its 3’→5’
antisense peptide predicted by means of the SSpro8 method
a-melanotropin
SY SMEHF RWGKPV
* * * E E E E E T T * * *
Antisense peptide
RMRYLVKAT P FGH
* * E EHE E * * * T * *
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Figure 2. Average number of possible antisense peptide amino
acid substitutions arising from the sense peptide readings in
3’→5’, 5’→3’ and in both directions.
Bioactive Sites
The peaks of hydrophilicity are found at the position of
extended peptide motifs/epitopes, which are often suc-
cessful in raising antibodies.9,19 We applied the Molecu-
lar Recognition Theory to define the motif LVKA as a
possible receptor site for the a-melanotropin receptor
binding motif EHFR (3’→ 5’ and 5’→ 3’). Quadripep-
tide EHFR at a-melanotropin positions 5–8 is predicted
to be of b-strand structure (Table II). It has been repor-
ted that b-strand peptide conformation and structural si-
milarity of the interacting peptides provide better bind-
ing affinity of the sense-antisense pairs.15–16 Two a-me-
lanotropin amino acids at positions 9–10 were excluded
since they belong to b-turn (Table II). An NCBInr pro-
tein database search of the motif LVKA confirmed that it
is present, as a possible binding site for a-melanotropin,
in a number of G-protein-coupled receptors, T cell re-
ceptor and antibody/immunoglobulin chains (Table III).
The analysis is consistent with the known data on possi-
ble receptor sites for the a-melanotropin and its im-
munomodulatory functions,1–7 and Blalock’s observation
that antibodies interact as a result of complementary
shape and reflect the form of the peptides.13
Binding sites predicted for the a-melanotropin in
Table IV indicate that some of the known immunomodu-
latory functions of this hormone may be explained by
means of the Molecular Recognition Theory, i.e., ligand-
receptor interactions of the complementary peptides. Im-
mune system molecules sharing fragments of antisense
peptide could account for the effects of a-melanotropin
on lymphocytes, antibodies and neutrophils.2,5,6 [tam-
buk et al.16 showed recently that cytoprotective effects
exerted by a-melanotropin were also abolished by
means of its antisense peptide. This confirmed the in vi-
tro binding results of Blalock and Bost.12,16
Empirical observations of specific interactions be-
tween complementary (antisense) peptides suggest that
the new concept of the proteomic code could prove valu-
able in bridging the gap between gene and protein cod-
ing systems.15 [tambuk et al.20–22 reported that the sec-
ondary protein structure could be accurately predicted
from the mRNA strings. However, a comparative analy-
sis of the interacting 2D and 3D peptide structures
within sense-antisense MRT pairs is missing at the mo-
ment. An extended, i.e., b-strand, peptide conformation
of the interacting sense-antisense pairs is thought to pro-
vide better binding,15,16 though some authors point out
that hydropathic complementarity per se is not responsi-
ble for the interaction between sense and antisense pep-
tides.15,16 A single, conclusive, and reproducible algo-
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TABLE III. Receptor and antibody binding sites for the a-melanotropin motif EHFR according to the Molecular Recognition Theory
a-melanotropin antisense motif LVKA Version [Homo sapiens] Location *
Putative G-protein coupled receptor gi|20152314|dbj|BAB89338.1| 165–168
G-protein-coupled receptor gi|2668608|gb|AAC51905.1| 8–11
Sphingolipid GPCR-1 (EDG1) gi|49457532|emb|CAG47065.1| 8–11
Seven transmembrane helix receptor gi|21928418|dbj|BAC05802.1| 144–147
T-cell receptor beta-chain gi|338983|gb|AAA61017.1| 30–33
Immunoglobulin heavy chain gi|47600815|emb|CAG29711.1| 11–14
Immunoglobulin alpha-1 chain gi|553351|gb|AAA52733.1| 3–6
Immunoglobulin gamma-chain gi|474960|gb|AAA58691.1| 30–33
Ig kappa chain variable region gi|16076485|emb|CAC94463.1| 4–7
Ig heavy chain variable region gi|10636616|emb|CAC10680.1| 11–14
IgE variable region gi|1197507|emb|CAA64959.1| 29–32
TABLE IV. Immune system molecules sharing the fragments of a-melanotropin 3’®5’ antisense motif RHRYLVKATPFGH
RHRYLVKAT P FGH Molecule [Homo sapiens] Location*
* * RYLV * * * * * * * Ig hc variable/VHDJ region 102–105/103–106
* * RYLVK * * * * * * T-cell receptor beta-chain 7–11, 16–20, 28–32, 36–40
* * RYLVK * * * * * * Interleukin 8 receptor type 2/B 154–158, 159–163
* * * * LVKAT P * * * Ig hc variable region 5–10
* * * * * * * AT P FG * Ig hc VHDJ region 102–106
rithm for efficient antisense peptide design, verified by
several independent research groups, is missing.15,16
CONCLUSION
Protein sequence analysis based on simple hydropathy
plots may be combined with complex methods of the se-
condary structure prediction in order to extract the infor-
mation relevant for the epitope location and modelling.
Following this first step, the Molecular Recognition
Theory with a subsequent database search may be ap-
plied to find possible receptor/paratope structures for
particular epitope ligands. The described concept could
constitute a useful and simple set of procedures for de-
riving new biologically active peptides, antibodies and
for performing peptide-receptor modulation.
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SA@ETAK
Alpha-melanotropni peptid: Struktura i prepoznavanje liganda i receptora
Karlo Houra, Nikola [tambuk, Pa{ko Konjevoda, Alenka Boban-Blagai},
Tomislav Bruketa i Biserka Pokri}
Istra`ivan je hidropatski profil, sekundarna struktura, epitop i vezno mjesto molekule a-melanotropina.
Pokazano je kako se standardni algoritam prema Kyte i Doolittleu mo`e kombinirati s kompleksnijim meto-
dama predikcije sekundarne strukture kako bi se dobila relevantna informacija o polo`aju i modeliranju epi-
topa. Vezanje ligand-receptor motiva navedenog hormona istra`ivano je pomo}u SSpro8 postupka. kako bi se
prona{li mogu}i paratopi (receptori) za predvi|ene a-melanotropinske epitope (ligande). Primijenjeno je i pre-
tra`ivanje NCBInr proteinske baze podataka pomo}u teorije molekularnog prepoznavanja. Opisani koncept
predstavlja koristan i jednostavan skup postupaka za izvo|enje novih biolo{ki aktivnih peptida i protutijela, kao
i za provo|enje modulacije interakcije sustava peptid-receptor.
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